BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37086688)

  • 21. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
    Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma.
    Zhou G; Zeng Y; Luo Y; Guo S; Bao L; Zhang Q
    Eur J Surg Oncol; 2022 Jan; 48(1):95-102. PubMed ID: 34175168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
    Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
    Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
    Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
    World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Wu J; Zhou X; Li P; Lin X; Wang J; Hu Z; Zhang P; Chen D; Cai H; Niessner R; Haisch C; Sun P; Zheng Y; Jiang Z; Zhou H
    Anal Chem; 2021 Jun; 93(25):8799-8809. PubMed ID: 34076420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
    Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
    Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An automated and mobile magnetoresistive biosensor system for early hepatocellular carcinoma diagnosis.
    Yao C; Ng E; Wang SX
    Biosens Bioelectron; 2022 Apr; 202():113982. PubMed ID: 35033828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.
    Bowers J; Hughes E; Skill N; Maluccio M; Raftery D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():154-62. PubMed ID: 24666728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).
    Reichl P; Mikulits W
    Oncol Rep; 2016 Aug; 36(2):613-25. PubMed ID: 27278244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
    Wang K; Guo WX; Li N; Gao CF; Shi J; Tang YF; Shen F; Wu MC; Liu SR; Cheng SQ
    PLoS One; 2015; 10(12):e0144934. PubMed ID: 26674525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
    Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
    Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.
    da Costa AN; Plymoth A; Santos-Silva D; Ortiz-Cuaran S; Camey S; Guilloreau P; Sangrajrang S; Khuhaprema T; Mendy M; Lesi OA; Chang HK; Oh JK; Lee DH; Shin HR; Kirk GD; Merle P; Beretta L; Hainaut P
    Int J Cancer; 2015 Jan; 136(1):172-81. PubMed ID: 24803312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.
    Liu T; Liu D; Liu R; Jiang H; Yan G; Li W; Sun L; Zhang S; Liu Y; Guo K
    Sci Rep; 2017 Jan; 7():38918. PubMed ID: 28079114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.